Summary
It is estimated that colorectal cancer (CRC) accounted for 12.7% of all new cancer diagnoses in the EU in 2020 and 12.4% of all deaths due to cancer. Of total CRC cases, it is believed that approximately 40 % harbour RAS mutations. Current treatment for RAS mutant (mt)...
More information & hyperlinks
Web resources: | https://www.colossusproject.eu/ |